Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03431818 · ClinicalTrials.gov registry record
Effective Fraction of Inspired Oxygen With Nasal Cannula in Premature Infants
A clinical trial, sponsored by University of Miami.
- Completed
- Registry status
- 35
- Enrollment target
NCT03431818 is a clinical trial that has completed, run by University of Miami. The registered enrollment target is 35 participants.
The verdict
NCT03431818 has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
The objective of this study is to determine the multifactorial relationship between the effective fraction of inspired oxygen (Effective-FiO2) and the FiO2 in the gas delivered by the nasal cannula (NC-FiO2), NC flow rate, spontaneous minute ventilation and other patient characteristics in premature infants who receive supplemental oxygen via nasal cannula (NC).
Interventions
- OTHER Nasal cannula flow rate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2018-04-04 |
| Est. Completion | 2023-09-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03431818
The ClinicalTrials.gov registry entry for NCT03431818 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nasal cannula flow rate is the first listed.
NCT03431818 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03431818 about?
NCT03431818 is a clinical study titled "Effective Fraction of Inspired Oxygen With Nasal Cannula in Premature Infants". The objective of this study is to determine the multifactorial relationship between the effective fraction of inspired oxygen (Effective-FiO2) and the FiO2 in the gas delivered by the nasal cannula (NC-FiO2), NC flow rate, spontaneous minute ventilation and other patient characteristics in premature...
What is the current status of trial NCT03431818?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2018-04-04. Estimated completion is 2023-09-07.
What interventions are being tested in trial NCT03431818?
The interventions under investigation include: Nasal cannula flow rate (OTHER).
Who is sponsoring clinical trial NCT03431818?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.